MS CONSULT / PEER REVIEWED

Cognition and MS

Author and Disclosure Information

 

References

Q)How are cognitive symptoms assessed?

There are several screening tools that take very little time to administer and can be used in the clinic setting. The Symbol Digit Modalities Test (SDMT; www.wpspublish.com/store/p/2955/sdmt-symbol-digit-modalities-test) is validated in MS and takes approximately 90 s to complete. This screening instrument is proprietary and has a small fee associated with its use.8

Other possible causes of cognitive dysfunction should be investigated as well. These include an examination of medications being used—such as anticholinergics, benzodiazepines, other sedatives, cannabis, topiramate, and opioids—and consideration of other diseases and conditions, including vascular conditions, metabolic deficiencies, infection, tumor, substance abuse, early dementia, or hypothyroidism, which may contribute to or cause cognitive impairment.

Should cognitive problems be identified—either through the history, during the clinic visit, or via screening tests—more formal testing, usually performed by a neuropsychologist, may be useful in identifying the domains of function that are impaired. This information can help to identify and implement appropriate compensatory strategies, plan cognitive rehabilitation interventions, and (in the United States) assist the individual to obtain Social Security disability benefits.

Q)How are cognitive symptoms managed?

Multiple clinical trials of cognitive rehabilitation strategies have demonstrated the efficacy of computer-based programs in improving new learning, short-term memory, processing speed, and attention.9 Cognitive rehabilitation programs should be administered and/or supervised by a health care professional who is knowledgeable about MS as well as cognitive rehabilitation. Professionals such as neuropsychologists, occupational therapists, and speech language pathologists often direct cognitive training programs.

Medications that stimulate the central nervous system have been used to improve mental alertness. However, clinical trials are few and have yielded mixed results.

Continue to: In clinical trials...

Recommended Reading

Prenatal valproate exposure raises ADHD risk
Clinician Reviews
Synthetic opioids drive spike in U.S. fatal drug overdoses
Clinician Reviews
Researchers exploring ways to mitigate aging’s impact on diabetes
Clinician Reviews
Treating OSA with positive airway pressure decreased amyloid levels in CSF
Clinician Reviews
Alcohol use, psychological distress associated with possible RBD
Clinician Reviews
Sleep disorders in children with ADHD treated with off-label medications
Clinician Reviews
Tic disorders are associated with obesity and diabetes
Clinician Reviews
Frailty may affect the expression of dementia
Clinician Reviews
Obesity paradox applies to post-stroke mortality
Clinician Reviews
How seizure prediction may benefit patients with epilepsy
Clinician Reviews